Related Experiment Video
Updated: Aug 8, 2026

Use of In vivo Imaging to Monitor the Progression of Experimental Mouse Cytomegalovirus Infection in Neonates
Published on: July 6, 2013
Enhancing antibodies, macrophages and virulence in mouse cytomegalovirus infection
Abstract:
The infectivity of tissue culture-passed mouse cytomegalovirus (MCMV) for resident mouse peritoneal macrophages in the presence of serial dilutions of antiviral antibody was studied by fluorescent antibody staining and virus yields. Although MCMV was neutralized by high concentrations of antiserum, there was a twofold enhancement of infectivity by subneutralizing antibody concentrations. On further dilution of antiserum, significant neutralization appeared again. When F(ab')2 fragments of anti-MCMV IgG were used or when macrophages were pretreated with monoclonal antibody to Fc receptor, there was no enhancement, and no neutralization at high dilutions of antiserum. This suggests that both enhancement and high dilution neutralization are mediated via the Fc portion of IgG and Fc receptors of macrophages. Tissue culture-passed virus whose infectivity for macrophages was reduced by high dilutions of antibody was converted to a more infectious state by addition of anti-mouse immunoglobulin. Similar results were obtained with salivary gland virus, which is less infectious for macrophages and is coated with non-neutralizing antibody. Tissue culture-passed virus is known to be less virulent for suckling mice and more infectious for macrophages than salivary gland-passed virus. When tissue culture-passed virus was coated with appropriately diluted antiviral antibody, not only was its infectivity for macrophages reduced, but it also became more virulent than control virus treated with normal mouse serum. These results are interpreted in terms of the optimal density of Fc on the virus-immunoglobulin complex in relation to the density of Fc receptors on macrophages.
Insights
Mouse cytomegalovirus (MCMV) infectivity for macrophages is enhanced by subneutralizing antibody concentrations, mediated by the Fc portion of IgG and macrophage Fc receptors. This phenomenon impacts MCMV virulence and macrophage interactions.
Area of Science:
- Immunology
- Virology
Background:
- Mouse cytomegalovirus (MCMV) infectivity varies depending on its passage history.
- Antibody interactions with viruses can modulate infectivity and pathogenicity.
Purpose of the Study:
- To investigate the effect of antiviral antibodies on MCMV infectivity for macrophages.
- To elucidate the mechanisms underlying antibody-mediated enhancement and neutralization of MCMV.
Main Methods:
- In vitro studies using tissue culture-passed MCMV and resident mouse peritoneal macrophages.
- Assays included fluorescent antibody staining and virus yield measurements.
- Experiments utilized F(ab')2 fragments and Fc receptor blocking to dissect antibody-mediated effects.
Main Results:
- Subneutralizing concentrations of anti-MCMV antibody enhanced MCMV infectivity for macrophages twofold.
- Enhancement and neutralization at high antibody dilutions were dependent on the Fc portion of IgG and macrophage Fc receptors.
- Coating MCMV with specific antibody concentrations altered its virulence in vivo.
Conclusions:
- Antibody-dependent enhancement of MCMV infectivity is mediated by Fc-Fc receptor interactions.
- The density of Fc on virus-immunoglobulin complexes influences macrophage interactions and viral pathogenicity.
- Understanding these interactions is crucial for MCMV pathogenesis and therapeutic strategies.
Related Concept Videos
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Cytomegalovirus Disease

